<p>Provided are a novel compound which exhibits a plasminogen activator inhibitor-1 (PAI-1) inhibiting activity, a PAI-1 inhibitor which comprises said compound as an active component; and a pharmaceutical composition which comprises the compound exhibiting a PAI-1 inhibiting activity as an active component and which is effective for the prevention and/or treatment of various diseases induced by the activity of PAI-1.</p>